Lessons from ALL-REZ BFM 90: therapy for childhood leukemia based on timing and site of relapse

Affiliations

Comment

Michael E Rytting. Curr Hematol Malig Rep. 2012 Mar.

. 2012 Mar;7(1):1-2.

doi: 10.1007/s11899-011-0112-z.

¹ University of Texas M.D. Anderson Cancer Center, Houston, TX 77030, USA. mrytting@mdanderson.org

No abstract available

Comment on

Long-term outcome in children with relapsed acute lymphoblastic leukemia after time-point and site-of-relapse stratification and intensified short-course multidrug chemotherapy: results of trial ALL-REZ BFM 90.
Tallen G, Ratei R, Mann G, Kaspers G, Niggli F, Karachunsky A, Ebell W, Escherich G, Schrappe M, Klingebiel T, Fengler R, Henze G, von Stackelberg A. Tallen G, et al. J Clin Oncol. 2010 May 10;28(14):2339-47. doi: 10.1200/JCO.2009.25.1983. Epub 2010 Apr 12. J Clin Oncol. 2010. PMID: 20385996 Clinical Trial.